Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Novel biomarkers for prediabetes, diabetes, and associated complications.

Dorcely B, Katz K, Jagannathan R, Chiang SS, Oluwadare B, Goldberg IJ, Bergman M.

Diabetes Metab Syndr Obes. 2017 Aug 14;10:345-361. doi: 10.2147/DMSO.S100074. eCollection 2017. Review.

2.

Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart Study.

Zachariah JP, Quiroz R, Nelson KP, Teng Z, Keaney JF Jr, Sullivan LM, Vasan RS.

J Am Heart Assoc. 2017 Jul 16;6(7). pii: e004974. doi: 10.1161/JAHA.116.004974.

3.

Role of fetuin A in the diagnosis and treatment of joint arthritis.

Pappa E, Perrea DS, Pneumaticos S, Nikolaou VS.

World J Orthop. 2017 Jun 18;8(6):461-464. doi: 10.5312/wjo.v8.i6.461. eCollection 2017 Jun 18. Review.

4.

The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-A.

Wagner R, Machann J, Guthoff M, Nawroth PP, Nadalin S, Saleem MA, Heyne N, Königsrainer A, Fend F, Schick F, Fritsche A, Stefan N, Häring HU, Schleicher E, Siegel-Axel DI.

Sci Rep. 2017 May 23;7(1):2261. doi: 10.1038/s41598-017-02210-4.

5.

α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease.

Manolakis AC, Christodoulidis G, Kapsoritakis AN, Georgoulias P, Tiaka EK, Oikonomou K, Valotassiou VJ, Potamianos SP.

World J Gastroenterol. 2017 Jan 21;23(3):437-446. doi: 10.3748/wjg.v23.i3.437.

6.

Serum vitamin D, intact parathyroid hormone, and Fetuin A concentrations were associated with geriatric sarcopenia and cardiac hypertrophy.

Chang WT, Wu CH, Hsu LW, Chen PW, Yu JR, Chang CS, Tsai WC, Liu PY.

Sci Rep. 2017 Jan 23;7:40996. doi: 10.1038/srep40996.

8.

The Cerebrovascular-Chronic Kidney Disease Connection: Perspectives and Mechanisms.

Lau WL, Huisa BN, Fisher M.

Transl Stroke Res. 2017 Feb;8(1):67-76. doi: 10.1007/s12975-016-0499-x. Epub 2016 Sep 14. Review.

9.

Novel phenotypes of prediabetes?

Häring HU.

Diabetologia. 2016 Sep;59(9):1806-18. doi: 10.1007/s00125-016-4015-3. Epub 2016 Jun 25. Review.

10.

Implication of hepatokines in metabolic disorders and cardiovascular diseases.

Jung TW, Yoo HJ, Choi KM.

BBA Clin. 2016 Mar 5;5:108-13. doi: 10.1016/j.bbacli.2016.03.002. eCollection 2016 Jun. Review.

11.

Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.

Aroner SA, St-Jules DE, Mukamal KJ, Katz R, Shlipak MG, Criqui MH, Kestenbaum B, Siscovick DS, de Boer IH, Jenny NS, Budoff MJ, Ix JH, Jensen MK.

Atherosclerosis. 2016 May;248:224-9. doi: 10.1016/j.atherosclerosis.2016.03.029. Epub 2016 Mar 22.

12.

The Impact of Organokines on Insulin Resistance, Inflammation, and Atherosclerosis.

Choi KM.

Endocrinol Metab (Seoul). 2016 Mar;31(1):1-6. doi: 10.3803/EnM.2016.31.1.1. Review.

13.

Serum and tissue biomarkers in aortic stenosis.

Kapelouzou A, Tsourelis L, Kaklamanis L, Degiannis D, Kogerakis N, Cokkinos DV.

Glob Cardiol Sci Pract. 2015 Nov 13;2015(4):49. doi: 10.5339/gcsp.2015.49. eCollection 2015.

14.

Fetuin-A and risk of coronary heart disease: A Mendelian randomization analysis and a pooled analysis of AHSG genetic variants in 7 prospective studies.

Laugsand LE, Ix JH, Bartz TM, Djousse L, Kizer JR, Tracy RP, Dehghan A, Rexrode K, Lopez OL, Rimm EB, Siscovick DS, O'Donnell CJ, Newman A, Mukamal KJ, Jensen MK.

Atherosclerosis. 2015 Nov;243(1):44-52. doi: 10.1016/j.atherosclerosis.2015.08.031. Epub 2015 Sep 5.

15.

Fetuin-A as a predicator of sarcopenic left ventricular dysfunction.

Chang WT, Tsai WC, Wu CH, Lee YW, Tai YL, Li YH, Tsai LM, Chen JH, Liu PY.

Sci Rep. 2015 Jul 10;5:12078. doi: 10.1038/srep12078.

16.

The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.

Celebi G, Genc H, Gurel H, Sertoglu E, Kara M, Tapan S, Acikel C, Karslioglu Y, Ercin CN, Dogru T.

Saudi J Gastroenterol. 2015 May-Jun;21(3):139-45. doi: 10.4103/1319-3767.157556.

17.

Usefulness of fetuin-A to predict risk for cardiovascular disease among patients with obstructive sleep apnea.

Liu A, Lamendola C, Ariel D, Abbasi F, Kim SH, Cardell J, Tomasso V, Xu S, Patel S, Mojaddidi H, Grove K, Kushida CA, Reaven GM.

Am J Cardiol. 2015 Jul 15;116(2):219-24. doi: 10.1016/j.amjcard.2015.04.014. Epub 2015 Apr 18.

18.

The effects of omega-3 fatty acid on vitamin D activation in hemodialysis patients: a pilot study.

Lee SM, Son YK, Kim SE, An WS.

Mar Drugs. 2015 Jan 28;13(2):741-55. doi: 10.3390/md13020741.

19.

Serum fetuin-A levels in patients with cardiovascular disease: a meta-analysis.

Sun ZL, Xie QY, Guo GL, Ma K, Huang YY.

Biomed Res Int. 2014;2014:691540. doi: 10.1155/2014/691540. Epub 2014 Oct 16.

20.

Clinical usefulness of novel serum and imaging biomarkers in risk stratification of patients with stable angina.

Tsaknis G, Tsangaris I, Ikonomidis I, Tsantes A.

Dis Markers. 2014;2014:831364. doi: 10.1155/2014/831364. Epub 2014 Jun 19. Review.

Supplemental Content

Support Center